Search Results - "нетравматическое субарахноидальное кровоизлияние"

1

Academic Journal

Nitric Oxide Donors in the Treatment of Vascular Spasm and Delayed Cerebral Ischemia in Patients with Subarachnoid Hemorrhage ; Донаторы оксида азота в терапии сосудистого спазма и отсроченной ишемии мозга у больных с субарахноидальным кровоизлиянием

Authors: S. V. Zhuravel, A. V. Prirodov, E. Yu. Bakharev, P. D. Zorin, S. S. Petrikov, С. В. Журавель, А. В. Природов, Е. Ю. Бахарев, П. Д. Зорин, С. С. Петриков

Contributors: This work was supported by an ANO grant (Agreement No. 1603-32/23с), Работа выполнена при поддержке гранта АНО (Соглашение No 1603-32/23с)

Source: Russian Sklifosovsky Journal "Emergency Medical Care"; Том 13, № 4 (2024); 656-667 ; Журнал им. Н.В. Склифосовского «Неотложная медицинская помощь»; Том 13, № 4 (2024); 656-667 ; 2541-8017 ; 2223-9022

Subject Terms: сосудистый спазм, non-traumatic subarachnoid hemorrhage, nitric oxide, nitric oxide donors, vasospasm, нетравматическое субарахноидальное кровоизлияние, монооксид азота, донаторы оксида азота

File Description: application/pdf

Relation: https://www.jnmp.ru/jour/article/view/2008/1510; https://www.jnmp.ru/jour/article/view/2008/1669; Крылов В.В., Винокуров А.Г., Дашьян В.Г., Лукьянчиков В.А., Полунина Н.А., Природов А.В. и др. Микрохирургия аневризм сосудов головного мозга. Москва: АБВ-пресс; 2022.; Лелюк В.Г., Лелюк С.Э. Церебральный ангиоспазм при субарахноидальных кровоизлияниях. Журнал неврологии и психиатрии им. С.С. Корсакова. 2011;111(8 Pt2):62–74. PMID: 22224249; Byrne JV, Griffith TM, Edwards DH, Harrison TJ, Johnston KR. Investigation of the vasoconstrictor action of subarachnoid haemoglobin in the pig cerebral circulation in vivo. Br J Pharmacol. 1989;97(3):669–674. PMID: 2788022 https://doi.org/10.1111/j.1476-5381.1989.tb12002.x; Edwards DH, Byrne JV, Griffith TM. The effect of chronic subarachnoid hemorrhage on basal endothelium-derived relaxing factor activity in intrathecal cerebral arteries. J Neurosurg. 1992;76(5):830–837. PMID: 1314293 https://doi.org/10.3171/jns.1992.76.5.0830; Fung C, Z’Graggen WJ, Jakob SM, Gralla J, Haenggi M, Rothen HU, et al. Inhaled Nitric Oxide Treatment for Aneurysmal SAH Patients With Delayed Cerebral Ischemia. Front Neurol. 2022;13:817072. PMID: 35250821 https://doi.org/10.3389/fneur.2022.817072; Siasios I, Kapsalaki EZ, Fountas KN. Cerebral vasospasm pharmacological treatment: an update. Neurol Res Int. 2013;2013:571328. PMID: 23431440 https://doi.org/10.1155/2013/571328; Rassaf T, Kleinbongard P, Preik M, Dejam A, Gharini P, Lauer T, et al. Plasma nitrosothiols contribute to the systemic vasodilator effectsof intravenously applied NO: experimental and clinical Study on the fate of NO in human blood. Circ Res. 2002;91(1):470–477. PMID: 12242264 https://doi.org/10.1161/01.res.0000035038.41739.cb; Kiriş T, Karasu A, Yavuz C, Erdem T, Unal F, Hepgül K, et al. Reversal of cerebral vasospasm by the nitric oxide donor SNAP in an experimental model of subarachnoid haemorrhage. Acta Neurochir (Wien). 1999;141(12):1323–1328. PMID: 10672304 https://doi.org/10.1007/s007010050437; Sehba FA, Ding WH, Chereshnev I, Bederson JB. Effects of Snitrosoglutathione on acute vasoconstriction and glutamate release after subarachnoid hemorrhage. Stroke. 1999;30(9):1955–1961. PMID: 10471450 https://doi.org/10.1161/01.str.30.9.1955; Clatterbuck RE, Gailloud P, Tierney T, Clatterbuck VM, Murphy KJ, Tamargo RJ. Controlled release of a nitric oxide donor for the prevention of delayed cerebral vasospasm following experimental subarachnoid hemorrhage in nonhuman primates. J Neurosurg. 2005;103(4):745–751. PMID: 16266059 https://doi.org/10.3171/jns.2005.103.4.0745; Gabikian P, Clatterbuck RE, Eberhart CG, Tyler BM, Tierney TS, Tamargo RJ. Prevention of Experimental Cerebral Vasospasm by Intracranial Delivery of a Nitric Oxide Donor From a Controlled-Release Polymer. Stroke. 2002;33(11):2681–2686. PMID: 12411661 https://doi.org/10.1161/01.str.0000033931.62992.b1; Pradilla G, Thai QA, Legnani FG, Hsu W, Kretzer RM, Wang PP, et al. Delayed intracranial delivery of a nitric oxide donor from a controlledrelease polymer prevents experimental cerebral vasospasm in rabbits. Neurosurgery. 2004;55(6):1393–1399. PMID: 15574221 https://doi.org/10.1227/01.neu.0000143615.26102.1a; Wolf EW, Banerjee A, Soble-Smith J, Dohan FC Jr, White RP, Robertson JT. Reversal of cerebral vasospasm using an intrathecally administered nitric oxide donor. J Neurosurg. 1998;89(2):279–288. PMID: 9688124 https://doi.org/10.3171/jns.1998.89.2.0279; Matsui T, Nagafuji T, Tsutsumi K, Uchida H, Miyauchi T, Asano T. The effect of Nicorandil on chronic cerebral vasospasm. Acta Neurochir (Wien). 1994;126(2–4):165–169. PMID: 8042550 https://doi.org/10.1007/BF01476428; Pluta RM, Dejam A, Grimes G, Gladwin MT, Oldfield EH. Nitrite infusions to prevent delayed cerebral vasospasm in a primate model of subarachnoid hemorrhage. Jama. 2005;293(12):1477–1484. PMID: 15784871 https://doi.org/10.1001/jama.293.12.1477; Lilla N, Hartmann J, Koehler S, Ernestus R-I, Westermaier T. Early NO-donor treatment improves acute perfusion deficit and brain damage after experimental subarachnoid hemorrhage in rats. J Neurol Sci. 2016;370:312–319. PMID: 27745692 https://doi.org/10.1016/j.jns.2016.09.032; Marbacher S, Neuschmelting V, Graupner T, Jakob SM, Fandino J. Prevention of delayed cerebral vasospasm by continuous intrathecal infusion of glyceroltrinitrate and nimodipine in the rabbit model in vivo. Intensive Care Med. 2008;34(5):932–938. PMID: 18214428 https://doi.org/10.1007/s00134-008-0995-x; Fathi AR, Marbacher S, Graupner T, Wehrli F, Jakob SM, Schroth G, et al. Continuous intrathecal glyceryl trinitrate prevents delayed cerebral vasospasm in the single-SAH rabbit model in vivo. Acta Neurochir (Wien). 2011;153(8):1669–1675. PMID: 21671141 https://doi.org/10.1007/s00701-011-1049-7; Allen GS. Cerebral arterial spasm. Part 8: The treatment of delayed cerebral arterial spasm in human beings. Surg Neurol. 1976;6(2):71–80. PMID: 951655; Iwanaga H, Okuchi K, Koshimae N, Goda K, Imanishi M, Tokunaga H, et al. Effects of intravenous nitroglycerin combined with dopamine on intracranial pressure and cerebral arteriovenous oxygen difference in patients with acute subarachnoid haemorrhage. Acta Neurochir (Wien). 1995;136(3–4):175–180. PMID: 8748850 https://doi.org/10.1007/BF01410622; Rose JC, Mayer SA. Optimizing blood pressure in neurological emergencies. Neurocrit Care. 2004;1(3):287–299. PMID: 16174926 https://doi.org/10.1385/NCC:1:3:287 Dosage error in article text. Erratum in: Neurocrit Care. 2006;4(1):98.; Oldfield EH, Loomba JJ, Monteith SJ, Crowley RW, Medel R, Gress DR, et al. Safety and pharmacokinetics of sodium nitrite in patients with subarachnoid hemorrhage: a phase IIa study. J Neurosurg. 2013;119(3):634–641. PMID: 23706046 https://doi.org/10.3171/2013.3.JNS13266; Pathak A, Mathuriya SN, Khandelwal N, Verma K. Intermittent low dose intrathecal sodium nitroprusside therapy for treatment of symptomatic aneurysmal SAH-induced vasospasm. Br J Neurosurg. 2003;17(4):306–310. PMID: 14579895 https://doi.org/10.1080/02688690310001601180; Kumar R, Pathak A, Mathuriya SN, Khandelwal N. Intraventricular sodium nitroprusside therapy: a future promise for refractory subarachnoid hemorrhage-induced vasospasm. Neurol India. 2003;51(2):197–202. PMID: 14571002; Thomas JE, McGinnis G. Safety of intraventricular sodium nitroprusside and thiosulfate for the treatment of cerebral vasospasm in the intensive care unit setting. Stroke. 2002;33(2):486–492. PMID: 11823657 https://doi.org/10.1161/hs0202.103410; Pachl J, Haninec P, Tencer T, Mizner P, Houst’ava L, Tomás R, et al. The effect of subarachnoid sodium nitroprusside on the prevention of vasospasm in subarachnoid haemorrhage. Acta Neurochir Suppl. 2005;95:141–145. PMID: 16463839 https://doi.org/10.1007/3-211-32318-x_31; Agrawal A, Patir R, Kato Y, Chopra S, Sano H, Kanno T. Role of intraventricular sodium nitroprusside in vasospasm secondary to aneurysmal subarachnoid haemorrhage: A 5-year prospective study with review of the literature. Minim Invasive Neurosurg. 2009;52(1):5–8. PMID: 19247898 https://doi.org/10.1055/s-0028-1085454; Kajita Y, Suzuki Y, Oyama H, Tanazawa T, Takayasu M, Shibuya M, et al. Combined effect of L-arginine and superoxide dismutase on the spastic basilar artery after subarachnoid hemorrhage in dogs. J Neurosurg. 1994;80(3):476–483. PMID: 8113861 https://doi.org/10.3171/jns.1994.80.3.0476; Pluta RM, Afshar JK, Thompson BG, Boock RJ, Harvey-White J, Oldfield EH. Increased cerebral blood flow but no reversal or prevention of vasospasm in response to L-arginine infusion after subarachnoid hemorrhage. J Neurosurg. 2000;92(1):121–126. PMID: 10616090 https://doi.org/10.3171/jns.2000.92.1.0121; Göksel HM, Ozüm U, Oztoprak I. The therapeutic effect of continuous intracisternal L-Arginine infusion on experimental cerebral vasospasm. Acta Neurochir (Wien). 2001;143(3):277–285. PMID: 11460916 https://doi.org/10.1007/s007010170108; Ozüm U, Aslan A, Karadağ O, Gürelik M, Taş A, Zafer Kars H. Intracisternal versus intracarotid infusion of L-arginine in experimental cerebral vasospasm. J Clin Neurosci. 2007;14(6):556–562. PMID: 17430779 https://doi.org/10.1016/j.jocn.2006.03.013; Ozüm U, Aslan A, Taş A, Kars HZ. Intracarotid L-arginine reverses motor evoked potential changes in experimental cerebral vasospasm. Turk Neurosurg. 2007;17(1):13–18. PMID: 17918672; Ehlert A, Schmidt C, Wölfer J, Manthei G, Jacobs AH, Brüning R, et al. Molsidomine for the prevention of vasospasm-related delayed ischemic neurological deficits and delayed brain infarction and the improvement of clinical outcome after subarachnoid hemorrhage: a single-center clinical observational study. J Neurosurg. 2016;124(1):51–58. PMID: 26162034 https://doi.org/10.3171/2014.12.JNS13846; Ehlert A, Manthei G, Hesselmann V, Mathias K, Bein B, Pluta R. A Case of Hyperacute Onset of Vasospasm After Aneurysmal Subarachnoid Hemorrhage and Refractory Vasospasm Treated with Intravenous and Intraventricular Nitric Oxide: A Mini Review. World Neurosurg. 2016;91:673.e11–8. PMID: 27109628 https://doi.org/10.1016/j.wneu.2016.04.047; Ehlert A, Starekova J, Manthei G, Ehlert-Gamm A, Flack J, Gessert M, et al. Nitric Oxide-Based Treatment of Poor-Grade Patients After Severe Aneurysmal Subarachnoid Hemorrhage. Neurocrit Care. 2020;32(3):742– 754. PMID: 31418143 https://doi.org/10.1007/s12028-019-00809-1; Bellapart J, Jones L, Bandeshe H, Boots R. Plasma endothelin-1 as screening marker for cerebral vasospasm after subarachnoid hemorrhage. Neurocrit Care. 2014;20(1):77–83. PMID: 23921571 https://doi.org/10.1007/s12028-013-9887-1; Macdonald RL, Higashida RT, Keller E, Mayer SA, Molyneux A, Raabe A, et al. Randomised trial of clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid hemorrhage undergoing surgical clipping (CONSCIOUS-2). Acta Neurochir Suppl. 2013;115:27–31. PMID: 22890639 https://doi.org/10.1007/978-3-7091-1192-5_7; Macdonald RL, Kassell NF, Mayer S, Ruefenacht D, Schmiedek P, Weidauer S, et al. Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1): randomized, double-blind, placebo-controlled phase 2 dose-finding trial. Stroke. 2008;39(11):3015–3021. PMID: 18688013 https://doi.org/10.1161/STROKEAHA.108.519942; Cho SS, Kim SE, Kim HC, Kim WJ, Jeon JP. Clazosentan for Aneurysmal Subarachnoid Hemorrhage: An Updated Meta-Analysis with Trial Sequential Analysis. World Neurosurg. 2019;123:418–424.e3. PMID: 30508597 https://doi.org/10.1016/j.wneu.2018.10.213; Endo H, Hagihara Y, Kimura N, Takizawa K, Niizuma K, Togo O, et al. Effects of clazosentan on cerebral vasospasm-related morbidity and all-cause mortality after aneurysmal subarachnoid hemorrhage: two randomized phase 3 trials in Japanese patients. J Neurosurg. 2022;137(6):1707–1717. PMID: 35364589 https://doi.org/10.3171/2022.2.JNS212914; Atalay B, Caner H, Cekinmez M, Ozen O, Celasun B, Altinors N. Systemic administration of phosphodiesterase V inhibitor, sildenafil citrate, for attenuation of cerebral vasospasm after experimental subarachnoid hemorrhage. Neurosurgery. 2006;59(5):1102–1107. PMID: 17143244 https://doi.org/10.1227/01.NEU.0000245605.22817.44; Han BH, Vellimana AK, Zhou ML, Milner E, Zipfel GJ. Phosphodiesterase 5 inhibition attenuates cerebral vasospasm and improves functional recovery after experimental subarachnoid hemorrhage. Neurosurgery. 2012;70(1):178–186. PMID: 21796010 https://doi.org/10.1227/NEU.0b013e31822ec2b0; Mukherjee KK, Singh SK, Khosla VK, Mohindra S, Salunke P. Safety and efficacy of sildenafil citrate in reversal of cerebral vasospasm: a feasibility study. Surg Neurol Int. 2012:3:3. PMID: 22347673 https://doi.org/10.4103/2152-7806.92164; Washington CW, Derdeyn CP, Dhar R, Arias EJ, Chicoine MR, Cross DT, et al. A Phase I proof-of-concept and safety trial of sildenafil to treat cerebral vasospasm following subarachnoid hemorrhage. J Neurosurg. 2016;124(2):318–327. PMID: 26314998 https://doi.org/10.3171/2015.2.JNS142752; Dhar R, Washington C, Diringer M, Zazulia A, Jafri H, Derdeyn C, et al. Acute Effect of Intravenous Sildenafil on Cerebral Blood Flow in Patients with Vasospasm After Subarachnoid Hemorrhage. Neurocrit Care. 2016;25(2):201–204. PMID: 26940913 https://doi.org/10.1007/s12028-016-0243-0; Faropoulos K, Tsolaki V, Georgakopoulou VE, Trakas I, Tarantinos K, Papalexis P, et al. Value of sildenafil treatment for the prevention of vasospasm-related delayed ischemic neurological deficits and delayed brain infarction following aneurysmal subarachnoid hemorrhage. Med Int (London). 2023;3(2):19. PMID: 37032716 https://doi.org/10.3892/mi.2023.79; Dorhout Mees SM, Rinkel GJ, Hop JW, Algra A, van Gijn J. Antiplatelet therapy in aneurysmal subarachnoid hemorrhage: a systematic review. Stroke. 2003;34(9):2285–2289. PMID: 12881605 https://doi.org/10.1161/01.STR.0000083621.44269.3E; Matsuda N, Naraoka M, Ohkuma H, Shimamura N, Ito K, Asano K, et al. Effect of Cilostazol on Cerebral Vasospasm and Outcome in Patients with Aneurysmal Subarachnoid Hemorrhage: A Randomized, DoubleBlind, Placebo-Controlled Trial. Cerebrovasc Dis. 2016;42(1–2):97–105. PMID: 27070952 https://doi.org/10.1159/000445509; Li L, Fu X, Qiu H, Shi P. Effects of cilostazol treatment for patients with aneurysmal subarachnoid hemorrhage: A meta-analysis of 14 studies. J Clin Neurosci. 2022;99:190–203. PMID: 35286971 https://doi.org/10.1016/j.jocn.2021.12.025; Dayyani M, Sadeghirad B, Grotta JC, Zabihyan S, Ahmadvand S, Wang Y, et al. Prophylactic Therapies for Morbidity and Mortality After Aneurysmal Subarachnoid Hemorrhage: A Systematic Review and Network MetaAnalysis of Randomized Trials. Stroke. 2022;53(6):1993–2005. PMID: 35354302 https://doi.org/10.1161/STROKEAHA.121.035699; Li YS, Shemmer B, Stone E, A Nardi M, Jonas S, Quartermain D. Neuroprotection by inhaled nitric oxide in a murine stroke model is concentration and duration dependent. Brain Res. 2013;1507:134–145. PMID: 23473843 https://doi.org/10.1016/j.brainres.2013.02.031; Terpolilli NA, Feiler S, Dienel A, Müller F, Heumos N, Friedrich B, et al. Nitric oxide inhalation reduces brain damage, prevents mortality, and improves neurological outcome after subarachnoid hemorrhage by resolving early pial microvasospasms. J Cereb Blood Flow Metab. 2016;36(12):2096–2107. PMID: 26661144 https://doi.org/10.1177/0271678X15605848; https://www.jnmp.ru/jour/article/view/2008

Availability: https://www.jnmp.ru/jour/article/view/2008
https://doi.org/10.23934/2223-9022-2024-13-4-656-667

View record from BASE

2

Academic Journal

Endovascular Methods of Prevention and Treatment of Vascular Spasm Due to Rupture of Cerebral Aneurysms: Pros and Cons ; Эндоваскулярные методики профилактики и лечения сосудистого спазма вследствие разрыва церебральных аневризм: за и против

Authors: A. V. Prirodov, E. Yu. Bakharev, A. A. Kalinkin, А. В. Природов, Е. Ю. Бахарев, А. А. Калинкин

Source: Russian Sklifosovsky Journal "Emergency Medical Care"; Том 10, № 4 (2021); 750-759 ; Журнал им. Н.В. Склифосовского «Неотложная медицинская помощь»; Том 10, № 4 (2021); 750-759 ; 2541-8017 ; 2223-9022

Subject Terms: химиоангиопластика, nontraumatic subarachnoid hemorrhage, cerebral angiospasm, endovascular treatment, balloon angioplasty, chemoangioplasty, нетравматическое субарахноидальное кровоизлияние, церебральный ангиоспазм, эндоваскулярное лечение, баллонная ангиопластика

File Description: application/pdf

Relation: https://www.jnmp.ru/jour/article/view/1280/1002; https://www.jnmp.ru/jour/article/view/1280/1104; Zubkov YN, Nikiforov BM, Shustin VA. Balloon catheter technique for dilatation of constricted cerebral arteries after aneurysmal SAH. Acta neurochirurgica. 1984;70(1–2):65–79. PMID: 6234754 https://doi.org/10.1007/BF01406044; Jun P, Ko NU, English JD, Dowd CF, Halbach VV, Higashida RT, et al. Endovascular treatment of medically refractory cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Am J Neuroradiol. 2010;31(10):1911–1916. PMID: 20616179 https://doi.org/10.3174/ajnr.A2183; Rahme R, Jimenez L, Pyne-Geithman GJ, Serrone J, Ringer AJ, Zuccarello M, et al. Endovascular management of posthemorrhagic cerebral vasospasm: Indications, technical nuances, and results. Acta Neurochir Suppl. 2013;115:107–112. PMID: 22890655 https://doi.org/10.1007/978-3-7091-1192-5_23; Zwienenberg-Lee M, Hartman J, Rudisill, Madden LK, Smith K, Eskridge J, et al. Effect of prophylactic transluminal balloon angioplasty on cerebral vasospasm and outcome in patients with Fisher grade III subarachnoid hemorrhage results of a phase II multicenter, randomized, clinical trial. Stroke. 2008;39(6):1759–1765. PMID: 18420953 https://doi.org/10.1161/STROKEAHA.107.502666; Newell DW, Elliott JP, Eskridge JM, Winn HR. Endovascular therapy for aneurysmal vasospasm. Crit Care Clin. 1999;15(4):685–699. PMID: 10569116 https://doi.org/10.1016/s0749-0704(05)70082-8; Patel AS, Griessenauer CJ, Gupta R, Adeeb N, Foreman PM, Shallwani H, et al. Safety and efficacy of noncompliant balloon angioplasty for the treatment of subarachnoid hemorrhage–induced vasospasm: a multicenter study. World Nurosurg. 2017;98:189–197. PMID: 27777162 https://doi.org/10.1016/j.wneu.2016.10.064; Schacht H, Küchler J, Boppel T, Leppert J, Ditz C, Schramm P, et al. Transluminal balloon angioplasty for cerebral vasospasm after spontaneous subarachnoid hemorrhage: A single-center experience. Clini Neurol Neurosurg. 2020;188:105590. PMID: 31759310 https://doi.org/10.1016/j.clineuro.2019.105590; Li K, Barras CD, Chandra RV, Kok HK, Maingard JT, Carter NS, et al. A review of the management of cerebral vasospasm after aneurysmal subarachnoid hemorrhage. World Neurosurg. 2019;126:513–527. PMID: 30898740 https://doi.org/10.1016/j.wneu.2019.03.083; Cho WS, Kim JE, Park SQ, Ko JK, Kim DW, Park JC, et al. Korean Clinical Practice Guidelines for Aneurysmal Subarachnoid Hemorrhage. J Korean Neurosurg Soc. 2018;61(2):127–166. PMID: 29526058 https://doi.org/10.3340/jkns.2017.0404.005; Connolly ES, Rabinstein AA, Carhuapoma JR, Derdeyn CP, Dion J, Higashida RT, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage a guideline for healthcare professionals from the American Heart Association/american Stroke Association. Stroke. 2012;43(6):1711–1737. PMID: 22556195 https://doi.org/10.1161/STR.0b013e3182587839; Committee for Guidelines for Management of Aneurysmal Subarachnoid Hemorrhage. Evidence-based guidelines for the management of aneurysmal subarachnoid hemorrhage. English Edition. Neurol Med Chir (Tokyo). 2012;43(6):355–429. PMID: 22912991 https://doi.org/10.2176/nmc.52.355; Eskridge JM, McAuliffe W, Song JK, Deliganis AV, Newell DW, Lewis DH, et al. Balloon angioplasty for the treatment of vasospasm: results of first 50 cases. Neurosurg. 1998;42(3):510–517. PMID: 9526985 https://doi.org/10.1097/00006123-199803000-00016; Grande A, Nichols C, Khan U, Pyne-Geithman G, Abruzzo T, Ringer A, et al. Treatment of post-hemorrhagic cerebral vasospasm: role of endovascular therapy. Acta Neurochir Suppl. 2011;110(Pt2):127–132. PMID: 21125458 https://doi.org/10.1007/978-3-7091-0356-2_23; Andaluz N, Tomsick TA, Tew JrJM, van Loveren HR, Yeh H-Sh, Zuccarello M. Indications for endovascular therapy for refractory vasospasm after aneurysmal subarachnoid hemorrhage: experience at the University of Cincinnati. Surgical Neurol. 2002;58(2):131–138. PMID: 12453652 https://doi.org/10.1016/s0090-3019(02)00789-9; Калинкин А.А., Петриков С.С. Химиоангиопластика в лечении сосудистого спазма у пациентов с разрывами аневризм артерий головного мозга. Анналы клинической и экспериментальной неврологии. 2017;11(3):60–67. https://doi.org/10.18454/ACEN.2017.3.9; Firlik KS, Kaufmann AM, Firlik AD, Jungreis CA, Yonas H. Intraarterial papaverine for the treatment of cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Surg Neurol. 1999;51(1):66–74. PMID: 9952126 https://doi.org/10.1016/s0090-3019(97)00370-4; Tsurushima H, Kamezaki T, Nagatomo Y, Hyodo A, Nose T. Complications Associated with Intraarterial Administration of Papaverine for Vasospasm Following Subarachnoid Hemorrhage. Neurol Med Chir (Tokyo). 2000;40(2):112–115. PMID: 10786100 https://doi.org/10.2176/nmc.40.112; McAuliffe W, Townsend M, Eskridge JM, Newell DW, Grady MS, Winn HR. Intracranial pressure changes caused during papaverine infusion for treatment of vasospasm. J Neurosurg. 1995;83(3):430–434. PMID: 7666218 https://doi.org/10.3171/jns.1995.83.3.0430; Carhuapoma JR, Qureshi AI, Tamargo RJ, Mathis JM, Hanley DF. Intraarterial papaverine-induced seizures: case report and literature review. Surg Neurol. 2001;56(3):159–163. PMID: 11597640 https://doi.org/10.1016/s0090-3019(01)00450-5; Albanese E, Russo A, Quiroga M, Willis JrRN, Mericle RA, Ulm AJ. Ultrahigh-dose intraarterial infusion of verapamil through an indwelling microcatheter for medically refractory severe vasospasm: initial experience. J Neurosurg. 2010;113(4):913–922. PMID: 19877802 https://doi.org/10.3171/2009.9.JNS0997; Микеладзе К.Г., Окишев Д.Н., Белоусова О.Б., Коновалов Ан.Н., Пилипенко Ю.В., Хейреддин А.С., и др. Интраартериальное введение верапамила для профилактики и лечения церебрального ангиоспазма после САК вследствие разрыва аневризм сосудов головного мозга. Вопросы нейрохирургии имени Н.Н. Бурденко. 2018;(4):23–31.; Ryu CW, Koh JS, Yu SY, Kim EJ. Vasogenic edema of the Basal Ganglia after intra-arterial administration of nimodipine for treatment of vasospasm. J Korean Neurosurg Soc. 2011;49(2):112–115. PMID: 21519500 https://doi.org/10.3340/jkns.2011.49.2.112; Adami D, Berkefeld J, Platz J, Konczalla J, Pfeilschifter W, Weidauer S, et al. Complication rate of intraarterial treatment of severe cerebral vasospasm after subarachnoid hemorrhage with nimodipine and percutaneous transluminal balloon angioplasty: Worth the risk? J Neuroradiology. 2019;46(1):15–24. https://doi.org/10.1016/j.neurad.2018.04.001; Kieninger M, Flessa J, Lindenberg N, Bele S, Redel A, Schneiker A, et al. Side effects of long-term continuous intra-arterial nimodipine infusion in patients with severe refractory cerebral vasospasm after subarachnoid hemorrhage. Neurocrit care. 2018;28(1):65–76. PMID: 28685393 https://doi.org/10.1007/s12028-017-0428-1; Linfante I, Delgado-Mederos R, Andreone V, Gounis M, Hendriks L, Wakhloo AK. Angiographic and hemodynamic effects of high concentration of intra-arterial nicardipine in cerebral vasospasm. Neurosurgery. 2008;63(6):1080–1086. PMID: 19057319 https://doi.org/10.1227/01.NEU.0000327698.66596.35; Schmidt U, Bittner E, Pivi S, Marota JA. Hemodynamic management and outcome of patients treated for cerebral vasospasm with intraarterial nicardipine and/or milrinone. Anesth Analg. 2010;110(3):895–902. PMID: 20185665 https://doi.org/10.1213/ANE.0b013e3181cc9ed8; Rosenberg N, Lazzaro MA, Lopes DK, Prabhakaran S. High-dose intra-arterial nicardipine results in hypotension following vasospasm treatment in subarachnoid hemorrhage. Neurocrit Care. 2011;15(3):400– 404. PMID: 21468780 https://doi.org/10.1007/s12028-011-9537-4; Enomoto Y, Yoshimura S, Yamada K, Iwama T. Convulsion during intraarterial infusion of fasudil hydrochloride for the treatment of cerebral vasospasm following subarachnoid hemorrhage. Neurol Med Chir (Tokyo). 2010;50(1):7–11. PMID: 20098018 https://doi.org/10.2176/nmc.50.7; Ishihara M, Yamanaka K, Nakajima S, Yamasaki M. Intracranial hemorrhage after intra-arterial administration of fasudil for treatment of cerebral vasospasm following subarachnoid hemorrhage: a serious adverse event. Neuroradiology. 2012;54(1):73–75. PMID: 21431852 https://doi.org/10.1007/s00234-011-0856-0; Fraticelli AT, Cholley BP, Losser MR, Saint Maurice J-P, Payen D. Milrinone for the treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Stroke. 2008; 39(3):893–898. PMID: 18239182 https://doi.org/10.1161/STROKEAHA.107.492447; Duman E, Karakoç F, Pinar HU, Dogan R, Fırat A, Yıldırım E. Higher dose intra-arterial milrinone and intra-arterial combined milrinonenimodipine infusion as a rescue therapy for refractory cerebral vasospasm. Interv Neuroradi. 2017;23(6):636–643. PMID: 28956512 https://doi.org/10.1177/1591019917732288; Suzuki S, Ito O, Sayama T, Goto K. Intra-arterial colforsin daropate for the treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Neuroradiology. 2010;52(9):837–845. PMID: 19953235 https://doi.org/10.1007/s00234-009-0631-7; Kassel NF, Helm G, Simmons N, Phillips CD, Cail WS. Treatment of cerebral vasospasm with intra-arterial papaverine. J Neurosurg. 1992;77(6):848–852. PMID: 1432125 https://doi.org/10.3171/jns.1992.77.6.0848; Kaku Y, Yonekawa Y, Tsukahara T, Kazekawa K. Superselective intraarterial infusion of papaverine for the treatment of cerebral vasospasm after subarachnoid hemorrhage. J Neurosurg. 1992;77(6):842–847. PMID: 1432124 https://doi.org/10.3171/jns.1992.77.6.0842; Clouston JE, Numaguchi Y, Zoarski GH, Aldrich EF, Simard JM, Zitnay KM. Intraarterial papaverine infusion for cerebral vasospasm after subarachnoid hemorrhage. AJNR Am J Neuroradiol. 1995;16(1):27– 38. PMID: 7900600; Sawada M, Hashimoto N, Tsukahara T, Nishi S, Kaku Y, Yoshimura S. Effectiveness of intra-arterially infused papaverine solutions of various concentrations for the treatment of cerebral vasospasm. Acta Neurochir (Wien). 1997;139(8):706–711. PMID: 9309284 https://doi.org/10.1007/BF01420042; Polin RS, Hansen CA, German P, Chadduck JB, Kassell NF. Intraarterially administered papaverine for the treatment of symptomatic cerebral vasospasm. Neurosurgery. 1998;42(6):1256–1267. PMID: 9632183 https://doi.org/10.1097/00006123-199806000-00031; Smith WS, Dowd CF, Johnston SC, Ko NU, DeArmond SJ, Dillon WP, et al. Neurotoxicity of intra-arterial papaverine preserved with chlorobutanol used for the treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Stroke. 2004;35(11):2518–2522. PMID: 15472097 https://doi.org/10.1161/01.STR.0000144682.00822.83; Hosmann A, Wang WT, Dodier P, Bavinzski G, Engel A, Herta J, et al. The Impact of Intra-Arterial Papaverine-Hydrochloride on Cerebral Metabolism and Oxygenation for Treatment of Delayed-Onset PostSubarachnoid Hemorrhage Vasospasm. Neurosurgery. 2019;87(4):712– 719. PMID: 31792510 https://doi.org/10.1093/neuros/nyz500; Biondi A, Ricciardi GK, Puybasset L, Abdennour L, Longo M, Chiras J, et al. Intra-arterial nimodipine for the treatment of symptomatic cerebral vasospasm after aneurysmal subarachnoid hemorrhage: preliminary results. AJNR Am J Neuroradiol. 2004;25(6):1067–1076. PMID: 15205150; Hui C, Lau KP. Efficacy of intra-arterial nimodipine in the treatment of cerebral vasospasm complicating subarachnoid haemorrhage. Clinical radiology. 2005;60(9):1030–1036. PMID: 16124986 https://doi.org/10.1016/j.crad.2005.04.004; Hänggi D, Turowski B, Beseoglu K, Yong M, Steiger HJ. Intraarterial nimodipine for severe cerebral vasospasm after aneurysmal subarachnoid hemorrhage: influence on clinical course and cerebral perfusion. AJNR Am J Neuroradiol. 2008;29(6):1053–1060. PMID: 18372422 https://doi.org/10.3174/ajnr.A1005; Kerz T, Boor S, Beyer C, Welschehold S, Schuessler A, Oertel J. Effect of intraarterial papaverine or nimodipine on vessel diameter in patients with cerebral vasospasm after subarachnoid hemorrhage. Br J of Neurosurgery. 2012;26(4):517–524. PMID: 22303863 https://doi.org/10.3109/02688697.2011.650737; Cho WS, Kang HS, Kim JE, Kwon O-K, Oh CW, Son YJ, et al. Intra-arterial nimodipine infusion for cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage. Interv Neuroradiol. 2011;17(2):169–178. PMID: 21696654 https://doi.org/10.1177/159101991101700205; Kim SS, Dong-Hyuk P, Dong-Jun L, Kang SH, Cho TH, Chung YG. Angiographic Features and Clinical Outcomes of Intra-Arterial Nimodipine Injection in Patients with Subarachnoid HemorrhageInduced Vasospasm. J Korean Neurosurg Soc. 2012;52(3):172–178. PMID: 23115657 https://doi.org/10.3340/jkns.2012.52.3.172; Ott S, Jedlicka S, Wolf S, Peter M, Pudenz C, Merker P, et al. Continuous selective intra-arterial application of nimodipine in refractory cerebral vasospasm due to aneurysmal subarachnoid hemorrhage. Biomed Res Int. 2014;2014:970741. PMID: 24527461 https://doi.org/10.1155/2014/970741; Narayan V, Pendharkar H, Devi BI, Bhat DI, Shukla DP. Aggressive management of vasospasm with direct intra-arterial nimodipine therapy. Neurol India. 2018;66(2):416–422. PMID: 29547164 https://doi.org/10.4103/0028-3886.227295; Badjatia N, Topcuoglu MA, Pryor JC, Rabinov JD, Ogilvy CS, Carter BS, et al. Preliminary experience with intra-arterial nicardipine as a treatment for cerebral vasospasm. ANJR Am J Neuroradiol. 2004;25(5):819–826. PMID: 15140728; Tejada JG, Taylor RA, Ugurel MS, Hayakawa M, Lee SK, Chaloupka JC. Safety and feasibility of intra-arterial nicardipine for the treatment of subarachnoid hemorrhage-related vasospasm: initial clinical experience with high-dose infusions. AJNR Am J Neuroradiol. 2007;28(5):844–848. PMID: 17494654; Shah QA, Memon MZ, Suri MF, Rodriguez GJ, Kozak OS, Taylor RA, et al. Super-selective intra-arterial magnesium sulfate in combination with nicardipine for the treatment of cerebral vasospasm in patients with subarachnoid hemorrhage. Neurocrit Care. 2009;11(2):190–198. PMID: 19370322 https://doi.org/10.1007/s12028-009-9209-9; Pandey P, Steinberg GK, Dodd R, Do HM, Marks MP. A simplified method for administration of intra-arterial nicardipine for vasospasm with cervical catheter infusion. Neurosurgery. 2012;71(1 Suppl Operative):77– 85. PMID: 22105209 https://doi.org/10.1227/NEU.0b013e3182426257; Park ES, Kim DW, Kang SD. Endovascular treatment of symptomatic vasospasm after aneurysmal subarachnoid hemorrhage: a three-year experience. J Cerebrovasc Endovascular Neurosurgery. 2017;19(3):155– 161. PMID: 29159148 https://doi.org/10.7461/jcen.2017.19.3.155; Feng L, Fitzsimmons BF, Young WL, Berman MF, Lin E, Aagaard BD, et al. Intra-administered verapamil as adjunct therapy for cerebral vasospasm: safety and 2-year experience. AJNR Am J Neuroradiol. 2002;23(8):1284–1290. PMID: 12223366; Keuskamp J, Murali R, Chao KH. High-dose intraarterial verapamil in the treatment of cerebral vasospasm after subarachnoid hemorrhage aneurysm. J Neurosurg. 2008;108(3):458–463. PMID: 18312091 https://doi.org/10.3171/JNS/2008/108/3/0458; Stuart RM, Helbok R, Kurtz P, Schmidt M, Fernandez L, Lee K, et al. Highdose intra-arterial verapamil for the treatment of cerebral vasospasm after subarachnoid hemorrhage: prolonged effects on hemodynamic parameters and brain metabolism. Neurosurgery. 2011;68(2):337–345. PMID: 21135735 https://doi.org/10.1227/NEU.0b013e318201be47; Tachibana E, Harada T, Shibuya M, Saito K, Takayasu M, Suzuki Y, et al. Intra-arterial infusion of fasudil hydrochloride for treating vasospasm following subarachnoid haemorrhage. Acta Neurochir (Wien). 1999;141(1):13–19. PMID: 10071681 https://doi.org/10.1007/s007010050260; Tanaka K, Minami H, Kota M, Kuwamura K, Kohmura E. Treatment of cerebral vasospasm with intra-arterial fasudil hydrochloride. Neurosurgery. 2005;56(2):214–223. PMID: 15670369 https://doi.org/10.1227/01.neu.0000147975.24556.bc; Iwabuchi S, Yokouchi T, Hayashi M, Sato K, Saito N, Hirata Y, et.al. Intra-arterial Administration of Fasudil Hydrochloride for Vasospasm Following Subarachnoid Haemorrhage: Experience of 90 Cases. Acta Neurochir. 2011;110(2):179–181. PMID: 21125468 https://doi.org/10.1007/978-3-7091-0356-2_33; Nakamura T, Matsui T, Hosono A, Okano A, Fujisawa N, Tsuchiya T, et al. Beneficial effect of selective intra-arterial infusion of fasudil hydrochloride as a treatment of symptomatic vasospasm following SAH. Acta Neurochir Suppl. 2013;115:81–85. PMID: 22890650 https://doi.org/10.1007/978-3-7091-1192-5_18; Arakawa Y, Kikuta K, Hojo M, Goto Y, Ishii A, Yamagata S. Milrinone for the treatment of cerebral vasospasm after subarachnoid hemorrhage: report of seven cases. Neurosurgery. 2001;48(4):723–730. PMID: 11322432 https://doi.org/10.1097/00006123-200104000-00004; Shankar JJ, dos Santos MP, Deus-Silva L, Lum C. Angiographic evaluation of the effect of intra-arterial milrinone therapy in patients with vasospasm from aneurysmal subarachnoid hemorrhage. Neuroradiology. 2011;53(2):123–128. PMID: 20549498 https://doi.org/10.1007/s00234-010-0720-7; Sherif C, Wambacher B, Loyoddin M, Karaic R, Krafft P, Valentin A, et al. Repeated combined endovascular therapy with milrinone and nimodipine for the treatment of severe vasospasm: preliminary results. Acta Neurochir Suppl. 2015;120:203–207. PMID: 25366625 https://doi.org/10.1007/978-3-319-04981-6_35; Suzuki S, Ito O, Sayama T, Yamaguchi S, Goto K, Sasaki T. Intraarterial injection of colforsin daropate hydrochloride for the treatment of vasospasm after aneurysmal subarachnoid hemorrhage: preliminary report of two cases. Neuroradiology. 2006;48(1):50–53. PMID: 16261335 https://doi.org/10.1007/s00234-005-0014-7; Suzuki S, Sato M, Ota S, Fukushima T, Ota A, Ota T, et al Intraarterial colforsin may improve the outcome of patients with aneurysmal subarachnoid hemorrhage: a retrospective study. World Neurosurg. 2012;78(3–4):295–259. PMID: 22120553 https://doi.org/10.1016/j.wneu.2011.10.046; https://www.jnmp.ru/jour/article/view/1280

Availability: https://www.jnmp.ru/jour/article/view/1280
https://doi.org/10.23934/2223-9022-2021-10-4-750-759

View record from BASE

3

Academic Journal

Age-dependent characteristics of specialized scale parameters in subarahnoidal hemorrhage of non-traumatic etiology ; Возрастзависимые особенности параметров специализированных шкал при субарахноидальном кровоизлиянии нетравматического генеза ; Залежні від віку особливості параметрів спеціалізованих шкал при субарахноїдальному крововиливі нетравматичного ґенезу

Authors: Polkovnikova, K. Yu.

Source: Zaporozhye Medical Journal; Vol. 22 No. 1 (2020) ; Запорожский медицинский журнал; Том 22 № 1 (2020) ; Запорізький медичний журнал; Том 22 № 1 (2020) ; 2310-1210 ; 2306-4145

Subject Terms: вікові особливості, нетравматичний субарахноїдальний крововилив, шкала GOSE, хі-квадрат, age factors, atraumatic subarachnoid hemorrhage, GOSE scale, chi-square, возрастные факторы, нетравматическое субарахноидальное кровоизлияние, хи-квадрат

File Description: application/pdf

Relation: http://zmj.zsmu.edu.ua/article/view/194504/198675; http://zmj.zsmu.edu.ua/article/view/194504

Availability: http://zmj.zsmu.edu.ua/article/view/194504

View record from BASE

4

Academic Journal

Age-dependent characteristics of specialized scale parameters in subarahnoidal hemorrhage of non-traumatic etiology

Authors: Polkovnikova, K. Yu.

Source: Zaporožskij Medicinskij Žurnal, Vol 22, Iss 1, Pp 60-65 (2020)
Zaporozhye Medical Journal; Vol. 22 No. 1 (2020)
Запорожский медицинский журнал; Том 22 № 1 (2020)
Запорізький медичний журнал; Том 22 № 1 (2020)

Subject Terms: chi-square, age factors, хі-квадрат, gose scale, GOSE scale, шкала GOSE, вікові особливості, 3. Good health, нетравматичний субарахноїдальний крововилив, нетравматическое субарахноидальное кровоизлияние, возрастные факторы, atraumatic subarachnoid hemorrhage, Medicine, хи-квадрат